Concepedia

Author

Erwin Sablon

Fujirebio (Belgium)

Also Known As

E SABLON, E Sablon, E. SABLON, E. Sablon, ERWIN SABLON, Erwin R. Sablon, Erwin Sablon, Sablon E.

121

Publications

5.9K

Citations

38

H-Index

98

Concepts

All Affiliations

Fujirebio (Belgium)Queen Mary HospitalUniversity of Hong KongKU LeuvenInserm
ES

About

Erwin Sablon is an author at Fujirebio (Belgium) specializing in medicine, hepatitis, and viral hepatitis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

22

30

1.8K

2

Public Health

9

9

579

3

Engineering

3

3

164

4

Natural Sciences

3

3

113

5

Health Sciences

2

2

117

Erwin Sablon

×

55

Publications

4.2K

Citations

36

H-Index

YearCitations

Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy

Man‐Fung Yuen, Erwin Sablon, Chee Kin Hui,

Hepatology

2001

388

Low Resistance to Adefovir Combined With Lamivudine: A 3-Year Study of 145 Lamivudine-Resistant Hepatitis B Patients

Pietro Lampertico, Mauro Viganò, E. Manenti,

Gastroenterology

2007

310

HBsAg seroclearance in chronic hepatitis B in the Chinese: Virological, histological, and clinical aspects

Man‐Fung Yuen, Danny Ka‐Ho Wong, Erwin Sablon,

Hepatology

2004

242

Long–Term Suppression of Hepatitis B E Antigen–Negative Chronic Hepatitis B by 24–Month Interferon Therapy

Pietro Lampertico, E. Del Ninno, Mauro Viganò,

Hepatology

2003

218

Hepatitis C Virus Genotype 7, a New Genotype Originating from Central Africa

Donald G. Murphy, Erwin Sablon, Jasmine Chamberland,

Journal of Clinical Microbiology

2014

217

Mapping the Lectin-Like Activity of Tumor Necrosis Factor

Rudolf Lucas, Stefan Magez, Robert De Leys,

Science

1994

192

Significance of Hepatitis B Genotype in Acute Exacerbation, Hbeag Seroconversion, Cirrhosis–Related Complications, and Hepatocellular Carcinoma

Man-Fung Yuen, Erwin Sablon, He-Jun Yuan,

Hepatology

2003

158

Monitoring Drug Resistance in Chronic Hepatitis B Virus (HBV)-Infected Patients during Lamivudine Therapy: Evaluation of Performance of INNO-LiPA HBV DR Assay

Anna S. Lok, Fabien Zoulim, Stephen Locarnini,

Journal of Clinical Microbiology

2002

153

Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0

Jannick Verbeeck, Mark J. Stanley, Jen Shieh,

Journal of Clinical Microbiology

2008

124

GlycoFibroTest Is a Highly Performant Liver Fibrosis Biomarker Derived from DNA Sequencer-based Serum Protein Glycomics

Dieter Vanderschaeghe, Wouter Laroy, Erwin Sablon,

Molecular & Cellular Proteomics

2009

118

Page 1